Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia
View/ Open
Author
CONSTANTINOU, CATERINA
FONTES DE OLIVEIRA, CIBELY CRISTINE
BUSQUETS, SILVIA
HE, JIANXIN
KESARWANI, MEENU
MINDRINOS, MICHAEL
ARGILÉS, JOSEP M.
Published Version
https://doi.org/10.3892/ijmm.2010.557Metadata
Show full item recordCitation
CONSTANTINOU, CATERINA, CIBELY CRISTINE FONTES DE OLIVEIRA, DIONYSSIOS MINTZOPOULOS, SILVIA BUSQUETS, JIANXIN HE, MEENU KESARWANI, MICHAEL MINDRINOS, LAURENCE G. RAHME, JOSEP M. ARGILÉS, and A. ARIA TZIKA. 2011. “Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.” International Journal of Molecular Medicine 27 (1): 15-24. doi:10.3892/ijmm.2010.557. http://dx.doi.org/10.3892/ijmm.2010.557.Abstract
Cancer patients commonly suffer from cachexia, a syndrome in which tumors induce metabolic changes in the host that lead to massive loss in skeletal muscle mass. Using a preclinical mouse model of cancer cachexia, we tested the hypothesis that tumor inoculation causes a reduction in ATP synthesis and genome-wide aberrant expression in skeletal muscle. Mice implanted with Lewis lung carcinomas were examined by in vivo 31P nuclear magnetic resonance (NMR). We examined ATP synthesis rate and the expression of genes that play key-regulatory roles in skeletal muscle metabolism. Our in vivo NMR results showed reduced ATP synthesis rate in tumor-bearing (TB) mice relative to control (C) mice, and were cross-validated with whole genome transcriptome data showing atypical expression levels of skeletal muscle regulatory genes such as peroxisomal proliferator activator receptor γ coactivator 1 ß (PGC-1ß), a major regulator of mitochondrial biogenesis and, mitochondrial uncoupling protein 3 (UCP3). Aberrant pattern of gene expression was also associated with genes involved in inflammation and immune response, protein and lipid catabolism, mitochondrial biogenesis and uncoupling, and inadequate oxidative stress defenses, and these effects led to cachexia. Our findings suggest that reduced ATP synthesis is linked to mitochondrial dysfunction, ultimately leading to skeletal muscle wasting and thus advance our understanding of skeletal muscle dysfunction suffered by cancer patients. This study represents a new line of research that can support the development of novel therapeutics in the molecular medicine of skeletal muscle wasting. Such therapeutics would have wide-spread applications not only for cancer patients, but also for many individuals suffering from other chronic or endstage diseases that exhibit muscle wasting, a condition for which only marginally effective treatments are currently available.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712618/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:11717592
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)